ZELLUNA IMMUNOTHERAPY AS
Pioneering TCR-NK cell therapies to eliminate solid cancers safely.
Översikt
- 9
- Anställda
- 53t NOK
- Omsättning
- 2016
- Grundat
Beskrivning
Zelluna is a biotechnology company dedicated to eradicating solid cancers through innovative immune therapies. Its core mission involves unleashing the immune system's power using pioneering T cell receptor (TCR) guided natural killer (NK) cell therapies, known as TCR-NK. This novel platform is desi...